Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.84B | 11.69B | 11.98B | 11.55B | 10.44B | 10.06B |
Gross Profit | 6.71B | 6.59B | 6.82B | 6.58B | 6.10B | 5.77B |
EBITDA | 1.38B | 1.44B | 1.66B | 1.52B | 1.23B | 1.61B |
Net Income | 606.45M | 716.89M | 815.98M | 752.57M | 522.25M | 840.87M |
Balance Sheet | ||||||
Total Assets | 14.75B | 15.37B | 15.76B | 15.14B | 14.36B | 14.87B |
Cash, Cash Equivalents and Short-Term Investments | 9.22B | 9.68B | 9.89B | 9.01B | 8.23B | 8.30B |
Total Debt | 0.00 | 0.00 | 0.00 | 209.00K | 1.32M | 4.87M |
Total Liabilities | 3.15B | 3.39B | 4.04B | 3.81B | 3.39B | 3.59B |
Stockholders Equity | 11.60B | 11.97B | 11.73B | 11.33B | 10.97B | 11.28B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 424.92M | 1.28B | 1.24B | 171.51M | 128.76M |
Operating Cash Flow | 0.00 | 429.11M | 1.46B | 1.49B | 644.88M | 586.57M |
Investing Cash Flow | 0.00 | -123.66M | 12.01M | -201.67M | 69.33M | -95.11M |
Financing Cash Flow | 0.00 | -522.74M | -513.51M | -513.58M | -777.32M | -502.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $6.35T | 28.57 | 11.70% | 0.81% | -5.48% | -10.98% | |
72 Outperform | $637.47B | 33.20 | 13.64% | 0.43% | 6.92% | 25.38% | |
71 Outperform | ¥32.98B | 14.06 | 3.64% | 0.01% | 35.73% | ||
69 Neutral | $2.67T | 37.26 | 15.31% | 1.39% | 8.65% | 12.22% | |
68 Neutral | ¥13.61B | 20.07 | 3.69% | -2.98% | -31.07% | ||
63 Neutral | $34.07B | 6.13 | -11.73% | 1.80% | 5.33% | -18.31% | |
54 Neutral | $5.56T | 39.02 | 7.94% | 0.63% | 6.21% | 6.41% |